MONTPELLIER, France & TOULOUSE, France--(BUSINESS WIRE)--Emercell SAS (Emercell) and Cell-Easy SAS (Cell-Easy) announced today the signing of a strategic agreement for the scale-up and manufacturing ...
Manufacturing difficulties are holding back the commercial development of heart disease cell therapies, according to researchers who say “cell free” treatment could be an easy-to-make alternative. A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback